99 related articles for article (PubMed ID: 7944402)
1. An unusual heparin-binding peptide from the carboxy-terminal hep-2 region of fibronectin.
Ingham KC; Brew SA; Migliorini M
Arch Biochem Biophys; 1994 Oct; 314(1):242-6. PubMed ID: 7944402
[TBL] [Abstract][Full Text] [Related]
2. Binding of heparin by type III domains and peptides from the carboxy terminal hep-2 region of fibronectin.
Ingham KC; Brew SA; Migliorini MM; Busby TF
Biochemistry; 1993 Nov; 32(46):12548-53. PubMed ID: 8241146
[TBL] [Abstract][Full Text] [Related]
3. A synthetic peptide, FN-C/H-V, from the C-terminal heparin-binding domain of fibronectin promotes adhesion of PMA stimulated U937 cells.
Kato K; Mohri H; Tamura T; Okubo T
Biochem Biophys Res Commun; 1997 Oct; 239(1):205-11. PubMed ID: 9345296
[TBL] [Abstract][Full Text] [Related]
4. The heparin III-binding domain of fibronectin (III4-5 repeats) binds to fibronectin and inhibits fibronectin matrix assembly.
Maqueda A; Moyano JV; Hernández Del Cerro M; Peters DM; Garcia-Pardo A
Matrix Biol; 2007 Oct; 26(8):642-51. PubMed ID: 17611093
[TBL] [Abstract][Full Text] [Related]
5. A synthetic peptide from the heparin-binding domain III (repeats III4-5) of fibronectin promotes stress-fibre and focal-adhesion formation in melanoma cells.
Moyano JV; Maqueda A; Albar JP; Garcia-Pardo A
Biochem J; 2003 Apr; 371(Pt 2):565-71. PubMed ID: 12519080
[TBL] [Abstract][Full Text] [Related]
6. The ShdA adhesin binds to the cationic cradle of the fibronectin 13FnIII repeat module: evidence for molecular mimicry of heparin binding.
Kingsley RA; Keestra AM; de Zoete MR; Bäumler AJ
Mol Microbiol; 2004 Apr; 52(2):345-55. PubMed ID: 15066025
[TBL] [Abstract][Full Text] [Related]
7. The novel recognition site in the C-terminal heparin-binding domain of fibronectin by integrin alpha 4 beta 1 receptor on HL-60 cells.
Mohri H; Katoh K; Iwamatsu A; Okubo T
Exp Cell Res; 1996 Feb; 222(2):326-32. PubMed ID: 8598221
[TBL] [Abstract][Full Text] [Related]
8. Heparin binding by fibronectin module III-13 involves six discontinuous basic residues brought together to form a cationic cradle.
Busby TF; Argraves WS; Brew SA; Pechik I; Gilliland GL; Ingham KC
J Biol Chem; 1995 Aug; 270(31):18558-62. PubMed ID: 7629186
[TBL] [Abstract][Full Text] [Related]
9. Identification of the anti-adhesive site buried within the heparin-binding domain of fibronectin.
Fukai F; Hasebe S; Ueki M; Mutoh M; Ohgi C; Takahashi H; Takeda K; Katayama T
J Biochem; 1997 Feb; 121(2):189-92. PubMed ID: 9089388
[TBL] [Abstract][Full Text] [Related]
10. Interaction of heparin with internally quenched fluorogenic peptides derived from heparin-binding consensus sequences, kallistatin and anti-thrombin III.
Pimenta DC; Nantes IL; de Souza ES; Le Bonniec B; Ito AS; Tersariol IL; Oliveira V; Juliano MA; Juliano L
Biochem J; 2002 Sep; 366(Pt 2):435-46. PubMed ID: 12000310
[TBL] [Abstract][Full Text] [Related]
11. Evidence that binding to the carboxyl-terminal heparin-binding domain (Hep II) dominates the interaction between plasma fibronectin and heparin.
Benecky MJ; Kolvenbach CG; Amrani DL; Mosesson MW
Biochemistry; 1988 Sep; 27(19):7565-71. PubMed ID: 3207688
[TBL] [Abstract][Full Text] [Related]
12. Interactions between type III domains in the 110 kDa cell-binding fragment of fibronectin.
Litvinovich SV; Ingham KC
J Mol Biol; 1995 May; 248(3):611-26. PubMed ID: 7752228
[TBL] [Abstract][Full Text] [Related]
13. Identification of the heparin-binding region of snake venom vascular endothelial growth factor (VEGF-F) and its blocking of VEGF-A165.
Yamazaki Y; Tokunaga Y; Takani K; Morita T
Biochemistry; 2005 Jun; 44(24):8858-64. PubMed ID: 15952792
[TBL] [Abstract][Full Text] [Related]
14. Interaction of heparin with fibronectin and isolated fibronectin domains.
Ingham KC; Brew SA; Atha DH
Biochem J; 1990 Dec; 272(3):605-11. PubMed ID: 2268289
[TBL] [Abstract][Full Text] [Related]
15. Structure-function relations of antithrombin III-heparin interactions as assessed by biophysical and biological assays and molecular modeling of peptide-pentasaccharide-docked complexes.
Tyler-Cross R; Sobel M; McAdory LE; Harris RB
Arch Biochem Biophys; 1996 Oct; 334(2):206-13. PubMed ID: 8900394
[TBL] [Abstract][Full Text] [Related]
16. Insertion and orientation of a synthetic peptide representing the C-terminus of the A1 domain of Shiga toxin into phospholipid membranes.
Saleh MT; Ferguson J; Boggs JM; Gariépy J
Biochemistry; 1996 Jul; 35(29):9325-34. PubMed ID: 8755710
[TBL] [Abstract][Full Text] [Related]
17. Interaction of N-terminal fragments of fibronectin with synthetic and recombinant D motifs from its binding protein on Staphylococcus aureus studied using fluorescence anisotropy.
Huff S; Matsuka YV; McGavin MJ; Ingham KC
J Biol Chem; 1994 Jun; 269(22):15563-70. PubMed ID: 8195201
[TBL] [Abstract][Full Text] [Related]
18. RGD-independent cell adhesion to the carboxy-terminal heparin-binding fragment of fibronectin involves heparin-dependent and -independent activities.
McCarthy JB; Skubitz AP; Qi Z; Yi XY; Mickelson DJ; Klein DJ; Furcht LT
J Cell Biol; 1990 Mar; 110(3):777-87. PubMed ID: 2307707
[TBL] [Abstract][Full Text] [Related]
19. Binding site in human plasma fibronectin to HL-60 cells localizes in the C-terminal heparin-binding region independently of RGD and CS1.
Fujita H; Mohri H; Kanamori H; Iwamatsu A; Okubo T
Exp Cell Res; 1995 Apr; 217(2):484-9. PubMed ID: 7698249
[TBL] [Abstract][Full Text] [Related]
20. Phage display mapping for peptide 11 sensitive sequences binding to laminin-1.
Kazmin DA; Hoyt TR; Taubner L; Teintze M; Starkey JR
J Mol Biol; 2000 May; 298(3):431-45. PubMed ID: 10772861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
